Evening of Art + Science 2015
Art meets science at the DIA
Taubman Institute’s 2015 fundraiser a rousing success
Ann Arbor — For the second year in a row, some of Michigan’s most eminent doctors joined forces with leading local and national artists in a unique project to fund high-risk, high-reward medical research by the most cutting-edge young scientists at the University of Michigan.
Supporting these early-career physicians and keeping them in the research arena was a top priority for the late A. Alfred Taubman, whose namesake institute at U-M awards grants to the most promising young clinician-researchers seeking new cures and treatments for their patients.
The May 14 event at the Detroit Institute of Arts celebrated the businessman-philanthropist’s dual passions — the quest for medical cures and the cultivation of the contemporary art scene.
Twenty physician-researchers of the A. Alfred Taubman Medical Research Institute – global thought leaders in areas like cancer, cardiovascular health, ALS and more – teamed up with painters, sculptors, jewelers and other creative virtuosos for mind-bending conversations about the intersection of discovery and creativity in their respective fields.
In visits to one another’s labs and studios, the artists and scientists found common ground in the process each uses to leap challenges, to refine new techniques and to test novel hunches and ideas.
In the laboratory, the process leads to life-giving new treatments and cures. In the studio, the journey of inspiration results in works of beauty and expression. The resulting one-of-a-kind creations — in media ranging from oils to textiles to gemstones — were auctioned during “An Evening of Art + Science” at the Detroit Institute of Arts.
Proceeds will fund the Taubman Institute's Emerging Scholars grants. Aimed at launching the laboratories of U-M's best and brightest young doctors, these grants of $50,000 per year for three years help ensure the next generation of medical breakthroughs. In just a few short years, Taubman Emerging Scholars have initiated nine human clinical trials of new treatments in fields ranging from cancer to inflammatory diseases.
Dr. Eva Feldman: Alfred Taubman as mentor, leader, friend
The source of his greatness lay in his willingness to challenge conventional thinking.
Emerging Scholars publish new findings on basal cell cancer
Ophthalmologists Alon Kahana, MD, PhD and Rajesh Rao, MD are trying to pinpoint when the common cancer turns dangerous.
Dr. Max Wicha receives $6.5 million to target cancer stem cells
The award from the National Cancer Institute will fuel research into the cells that cause metastasis.
news & events
In the News
Taubman Emerging Scholar partners in ACL repair study
Asheesh Bedi, M.D., is an investigator in a study using human growth hormone to aid healing of the common knee injury.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D. and team find a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Arthritis drug may help diabetics with kidney disease
Research led by Taubman Scholar Frank Brosius has led to a fast-track study that shows promising results